Product Detail
|
|||||||||
| Customer Reviews |
| Be the first to review this product |
Additional Description
Table of Contents
Guidelines Panel Roster v
Summary vi
Introduction 1
Use of Testing for Plasma HIV RNA Levels and CD4 - T
Cell Count in Guiding Decisions for Therapy 2
Testing for Drug Resistance 3
Considerations for Patients with Establish HIV Infection 6
Considerations for Initiating Therapy in the Patient with
Asymptomatic HIV Infection 6
Considerations for Discontinuing Therapy 9
Adherence to Potent Antiretroviral Therapy 9
Goals of Therapy 14
Initiating Therapy in the Patient with Asymptornatic HIV
Infection 15
Initiating Therapy in Advanced HIV Disease 17
HAART-Associated Adverse Clinical Events 19
Interruption of Antiretroviral Therapy 22
Considerations for Changing a Failing Regimen 22
Criteria for Changing Therapy 23
Therapeutic Options When Changing Antiretroviral Therapy
24
Acute HIV Infection 25
Considerations for Antiretroviral Therapy in the
HIV-Infected Adolescent 28
Considerations for Antiretroviral Therapy in the
HIV-Infected Pregnant Woman 28
Conclusion 33
Tables 34
References 66
Considerations for Antiretroviral Therapy in Women 79
Hydroxyurea 83
Safety and Toxicity of Individual Antiretroviral Agents in
Pregnancy 85
